Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alps Medical Breakthroughs ETF (SBIO)

Alps Medical Breakthroughs ETF (SBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ALPS Advisors
  • Assets Under Management 143,602,800
  • Shares Outstanding, K 2,530
  • 60-Month Beta 0.80
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 1.173 on 12/19/24
  • Management Fee 0.50%
  • INDUSTRY GROUPING:

    ETFs - Healthcare

Options Overview Details

View History
  • Implied Volatility 28.64% (+0.14%)
  • Historical Volatility 36.41%
  • IV Percentile 24%
  • IV Rank 39.99%
  • IV High 53.58% on 10/03/25
  • IV Low 12.03% on 09/05/25
  • Expected Move (DTE 25) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 98
  • Open Int (30-Day) 126
  • Expected Range 56.76 to 56.76

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.63 +19.17%
on 03/24/26
57.77 -1.75%
on 04/17/26
+8.43 (+17.44%)
since 03/20/26
3-Month
47.63 +19.17%
on 03/24/26
57.77 -1.75%
on 04/17/26
+4.79 (+9.22%)
since 01/20/26
52-Week
26.28 +115.94%
on 04/21/25
57.77 -1.75%
on 04/17/26
+30.28 (+114.35%)
since 04/17/25

Most Recent Stories

More News
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure

Hunting for upside potential typically reserved for the private equity world? Look no further.

SBIO : 56.76 (-1.46%)
GNOM : 47.62 (+0.70%)
IBB : 175.76 (-0.51%)
Galapagos Announces CFO Exit With No Successor Named Yet: Retail’s Disappointed

The company expects to announce a new CFO “in the coming months.”

SBIO : 56.76 (-1.46%)
SPDW : 49.32 (-0.42%)
GLPG : 29.28 (unch)
Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely?

Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.

GURU : 66.89 (+0.79%)
GDOC : 33.44 (-0.90%)
SBIO : 56.76 (-1.46%)
MLTX : 17.89 (-2.45%)
Why Biotech ETFs Are Beating the Market

Biotech stocks have been outperforming the broader market over the past three months, driven by optimism regarding potential rate cuts. The Fed is expected to start cutting rates later this month, and...

SBIO : 56.76 (-1.46%)
IBB : 175.76 (-0.51%)
GILD : 135.87 (-1.29%)
REGN : 749.41 (-0.15%)
XBI : 137.79 (-0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Fund Summary

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200...

See More

Key Turning Points

3rd Resistance Point 57.84
2nd Resistance Point 57.60
1st Resistance Point 57.18
Last Price 56.76
1st Support Level 56.52
2nd Support Level 56.28
3rd Support Level 55.86

See More

52-Week High 57.77
Last Price 56.76
Fibonacci 61.8% 45.74
Fibonacci 50% 42.03
Fibonacci 38.2% 38.31
52-Week Low 26.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.